Page images
PDF
EPUB

14. In 84:94-36

DRUG ABUSE OFFICE AND TREATMENT ACT

AMENDMENTS OF 1975

941

HEARINGS

BEFORE THE

SUBCOMMITTEE ON

HEALTH AND THE ENVIRONMENT

OF THE

COMMITTEE ON

INTERSTATE AND FOREIGN COMMERCE
HOUSE OF REPRESENTATIVES

NINETY-FOURTH CONGRESS

FIRST SESSION

ON

H.R. 7547

A BILL TO AMEND THE DRUG ABUSE OFFICE AND TREAT-
MENT ACT OF 1972 AND FOR OTHER PURPOSES

AND

H.R. 4819

A BILL TO AMEND THE PUBLIC HEALTH SERVICE ACT,
THE COMPREHENSIVE ALCOHOL ABUSE AND ALCOHOLISM
PREVENTION, TREATMENT, AND REHABILITATION ACT OF
1970, THE DRUG ABUSE OFFICE AND TREATMENT ACT OF
1972, AND THE SOCIAL SECURITY ACT, TO REVISE AND EX-
TEND PROGRAMS OF HEALTH SERVICES, AND FOR OTHER

PURPOSES

JUNE 10 AND 11, 1975

Serial No. 94-36

Printed for the use of the Committee on Interstate and Foreign Commerce

57-278 O

U.S. GOVERNMENT PRINTING OFFICE

WASHINGTON: 1975

COMMITTEE ON INTERSTATE AND FOREIGN COMMERCE

HARLEY O. STAGGERS, West Virginia, Chairman

TORBERT H. MACDONALD, Massachusetts

JOHN E. MOSS, California

JOHN D. DINGELL, Michigan

PAUL G. ROGERS, Florida

LIONEL VAN DEERLIN, California
FRED B. ROONEY, Pennsylvania
JOHN M. MURPHY, New York

DAVID E. SATTERFIELD III, Virginia
BROCK ADAMS, Washington

W. S. (BILL) STUCKEY, JR., Georgia
BOB ECKHARDT, Texas
RICHARDSON PREYER, North Carolina
JAMES W. SYMINGTON, Missouri
CHARLES J. CARNEY, Ohio
RALPH H. METCALFE, Illinois
GOODLOE E. BYRON, Maryland
JAMES H. SCHEUER, New York
RICHARD L. OTTINGER, New York
HENRY A. WAXMAN, California
ROBERT (BOB) KRUEGER, Texas
TIMOTHY E. WIRTH, Colorado
PHILIP R. SHARP, Indiana

WILLIAM M. BRODHEAD, Michigan

W. G. (BILL) HEFNER, North Carolina
JAMES J. FLORIO, New Jersey

ANTHONY TOBY MOFFETT, Connecticut
JIM SANTINI, Nevada

ANDREW MAGUIRE, New Jersey

SAMUEL L. DEVINE, Ohio

JAMES T. BROYHILL, North Carolina
TIM LEE CARTER, Kentucky
CLARENCE J. BROWN, Ohio
JOE SKUBITZ, Kansas

JAMES F. HASTINGS, New York
JAMES M. COLLINS, Texas
LOUIS FREY, JR., Florida
JOHN Y. MCCOLLISTER, Nebraska
NORMAN F. LENT, New York
H. JOHN HEINZ III, Pennsylvania
EDWARD R. MADIGAN, Illinois
CARLOS J. MOORHEAD, California
MATTHEW J. RINALDO, New Jersey

[blocks in formation]

DAVID E. SATTERFIELD III, Virginia TIM LEE CARTER, Kentucky
RICHARDSON PREYER, North Carolina
JAMES W. SYMINGTON, Missouri
JAMES H. SCHEUER, New York
HENRY A. WAXMAN, California

JAMES T. BROYHILL, North Carolina
JAMES F. HASTINGS, New York

W. G. (BILL) HEFNER, North Carolina
JAMES J. FLORIO, New Jersey
CHARLES J. CARNEY, Ohio
ANDREW MAGUIRE, New Jersey
HARLEY O. STAGGERS, West Virginia

(Ex Officio)

H. JOHN HEINZ III, Pennsylvania
SAMUEL L. DEVINE, Ohio

( Officio)

STEPHAN E. LAWTON, Counsel
Jo ANNE GLISSON, Staff Assistant
STEPHEN J. CONNOLLY, Staff Assistant
DONALD K. DALRYMPLE, Assistant Counsel

(II)

[merged small][merged small][merged small][ocr errors][merged small][merged small][merged small][merged small]

Schramm, N. T., president, California Conference on Methadone

Programs..

Sopper, Dale W., Acting Deputy Assistant Secretary for Legislation

(Health), Department of Health, Education, and Walfare__

Additional material submitted for the record by-

American Hospital Association, Leo J. Gehrig, M.D., vice president,

letter dated June 6, 1975, to Chairman Rogers-

Health, Education, and Welfare Department:

Drug abuse costs, 1972-75 and cost-benefit studies-

Drug abuse emergency room mentions-March 1974-February

1975...

Interstate and Foreign Commerce Committee, text of Public Law

92-255, the Drug Abuse Office and Treatment Act of 1972.

National Association of State Drug Abuse Program Coordinators:

Attachments to Mr. Hesse's prepared statement:

Proposed amendments to H.R. 7547 and S. 1608___

Analysis of the President's drug abuse budget proposal.

Resolution approved by the NASDAPC board on June 3,

1975, and by action of its members on June 5, 1975, re

Public Law 92-255--

National Coordinating Council on Drug Education:

Attachment to Mr. Perito's prepared statement, drug abuse

prevention programs, fiscal years 1969-76--

Letter dated June 26, 1975, from Jospeh F. Corcoran, executive

director, NCCDE, re supplemental comments to Mr. Perito's

oral statement, with attachments---

Drug abuse prevention programs, fiscal years 1969–76_-

Letter dated May 23, 1975, from Jospeh F. Corcoran, ex-

ecutive director, NCCDE, to Senator William Hathaway,

chairman, Senate Subcommittee on Alcoholism and

Narcotics___

National Council of Community Mental Health Centers, Jonas V.
Morris, Washington representative, letter dated June 19, 1975, to
Chairman Rogers..

National League of Cities and U.S. Conference of Mayors, statement__

[merged small][merged small][merged small][merged small][merged small][merged small][merged small][merged small][ocr errors][merged small][merged small][merged small][merged small][merged small]
[blocks in formation]

Additional material submitted for the record by-Continued
Special Action Office for Drug Abuse Prevention:

Attachments to Dr. DuPont's prepared statement:

Page

Table 1.-National trends in hepatitis: 1966–71.
Table 2.-Estimated incidences of heroin use: 1960-71___
Table 3.-Hepatitis trends for different demographic groups:
1969-73-

170

171

172

Table 4.-The "age" of the heroin problem in major metro-
politan areas--

172

Table 5.-Year of peak incidence in small cities

173

Table 6.-Heroin price and purity-1972-74, retail heroin
availability-April 1972 to March 1975..

173

Table 7.-Year of first heroin use reported by new patients
admitted to NTA 1970-74--

174

Table 8.-East coast (Boston, Philadelphia, Washington,
and Miami) SMSAS heroin-related emergency room visits
to DAWN facilities: July 1973-Sept. 1974.
Table 9.-Use patterns of amphetamines and barbiturates-
1969, 1970, 1974.

175

164

Table 10.-Drug use from a nationwide sample of males-
1974.

Table 11.-Total funds for Federal drug abuse prevention
and law enforcement programs: fiscal years 1969-76_----
Correspondence between the Special Action Office on Drug Abuse
Prevention and the Department of Defense on the subject of
urinalysis..

Major drugs creating problems; emergency rooms, crisis center,
and medical examiner data_

Readmissions_.

Table 1-1.-Summary of adult experience with 12 types of drugs..
Table 1-2.-Summary of youth experience with 12 types of
drugs __

176

176

185

180

180

183

18

DRUG ABUSE OFFICE AND TREATMENT ACT

AMENDMENTS OF 1975

TUESDAY, JUNE 10, 1975

HOUSE OF REPRESENTATIVES,

SUBCOMITTEE ON HEALTH AND THE ENVIRONMENT,

COMMITTEE ON INTERSTATE AND FOREIGN COMMERCE,

Washington, D.C.

The subcommittee met at 1:30 p.m., pursuant to notice, in room 2123, Rayburn House Office Building, Hon. Paul G. Rogers, chairman, presiding.

Mr. ROGERS. The subcommittee will come to order please.

This afternoon the Subcommittee on Health and the Environment begins two days of legislative hearings to consider H.R. 7547, and H.R. 4819, bills which would substantially revise and extend the provisions of the Drug Abuse Office and Treatment Act of 1972, which expires on June 30, 1975.

The 1972 act, in recognition of the rapid growth of drug abuse and the attendant social, economic, and enforcement problems and the lack of a coordinated effort by the Federal, State, and local agencies to control and treat drug abuse, created the Special Action Office for Drug Abuse Prevention (SAODAP).

As you know, the statutory mission of SAODAP was and is to provide overall planning and policy and establish objectives and priorities for all Federal drug abuse prevention functions.

The 1972 act also provided supplemental support to community mental health centers for drug abuse treatment activities, formula grants to the States to help meet the costs of State drug abuse treatment and prevention activities, and special project grants and contracts for treatment, education, counseling, and research programs.

At the time of enactment of the 1972 act, many people felt that a coordinated national effort would have an immediate and positive effect with respect to drug abuse. Unfortunately, despite what would appear to be a concerted Federal effort, the problems of drug abuse are still very much with us. In fact, all indicators show that drug abuse is increasing in the United States today, particularly the abuse of heroin.

As we begin this series of hearings and our consideration of legislation to extend the 1972 act, the subcommittee is anxious to learn what progress has been made in developing a comprehensive, coordinated long-term Federal strategy encompassing both effective law enforcement against illegal drug traffic and effective health programs to rehabilitate victims of drug abuse.

(1)

« PreviousContinue »